Deals

Calhoun Vision Stages Turnaround

Calhoun Vision Stages Turnaround

By Larry Haimovitch | July 15, 2015

Medtech companies in ophthalmology have made some significant strides in recent months. Second Sight and Glaukos, of course, staged IPOs in their pursuit of revolutionary…

Read More
Allergan’s Oculeve Acquisition Bolsters Dry Eye, Medtech

Allergan’s Oculeve Acquisition Bolsters Dry Eye, Medtech

By Tom Salemi | July 9, 2015

The dry eye space has taken a few hits lately with disappointing clinical news on the biopharmaceutical front. But investors and entrepreneurs developing new treatments…

Read More
CMS Opens Sunshine Act Review

CMS Opens Sunshine Act Review

By Tom Salemi | April 13, 2015

Physicians have 45 days to review and dispute payments from industry. The Ophthalmology Innovation Summit opening on Thursday is clear evidence of the advances that…

Read More
Eye Companies Helping Health Care Stand Out

Eye Companies Helping Health Care Stand Out

By Rich Kirkner | November 11, 2014

Healthcare stocks are outperforming the indices, and ophthalmic companies are helping to fuel a large part of that growth, Jeffrey Hoffman, Managing Director and Head…

Read More
CEOs Share Their ‘Second Acts’ On Way to Building Successful Companies

CEOs Share Their ‘Second Acts’ On Way to Building Successful Companies

By Rich Kirkner | November 11, 2014

Building a successful biotech or biopharma company typically turns on a sentinel event — the pivot, as William J. Link, PhD, Managing Director of Versant…

Read More
Digital Health Companies Poised to Grow

Digital Health Companies Poised to Grow

By Tom Salemi | November 11, 2014

When the OIS started its digital showcase in 2012, there was only one company presenting in the category. “Today there are six—evidence that this area…

Read More
AAO Sees Good and Bad in Consolidation

AAO Sees Good and Bad in Consolidation

By Tom Salemi | November 11, 2014

Speaking at the recent OIS@AAO meeting, American Academy of Ophthalmology EVP and CEO David W. Parke II, MD, highlighted health care system integration forces that…

Read More
How Do You Talk to an Angel?

How Do You Talk to an Angel?

By Tom Salemi | October 11, 2014

Ophthalmic Surgeon, Eric D. Kanter, MD, of Retina-Vitreous Consultants, balances his work at his busy New Jersey practice with his commitments as a principal member…

Read More
Ophthalmology Leaders Speak to Strength of Sector

Ophthalmology Leaders Speak to Strength of Sector

By Tom Salemi | September 17, 2014

A Wall Street Journal analysis of venture capital commitments showed ophthalmology remained the strongest sector within healthcare. According to the Wall Street Journal, privately held…

Read More
Avedro Broadens Cross-Link Product Line

Avedro Broadens Cross-Link Product Line

By Tom Salemi | September 9, 2014

Corneal collagen cross-linking has been a vexing specialty for US-based companies trying to guide a product through a cautious FDA. But Massachusetts-based Avedro Inc., continues…

Read More
WaveTec “Must Have” for Alcon

WaveTec “Must Have” for Alcon

By Tom Salemi | September 2, 2014

WaveTec Vision Systems’ CEO, Tom Frinzi, delivered a bottom-line presentation at the Ophthalmology Innovation Summit @ASCRS in Boston. His six-minute presentation concentrated on the economic…

Read More
More Value to Ophthalmic Innovators Working with Strategic Investors

More Value to Ophthalmic Innovators Working with Strategic Investors

By Tom Salemi | September 24, 2013

Evan Norton of Abbott Ventures sees a trend in which corporate investors are moving up their game to an earlier development stage, which could result…

Read More

SUBSCRIBE TO OIS NEWS

Get Our Weekly Newsletter About The Latest In Ophthalmic Innovation.

We respect your privacy and promise to never send you spam.

Something went wrong. Please check your entries and try again.